Immunic Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio4.892.340.551.982.00
Price/Tangible Book4.892.340.552.672.52
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-4.24%-1.31%-1.00%-0.65%-0.41%
Return on Assets (ROA)-1.29%-0.68%-0.41%-0.30%-0.26%
Return on Capital Employed (ROCE)-5.25%-3.36%-0.75%-0.58%-0.31%
Leverage & Solvency Ratios
Debt/Equity0.050.050.010.010.01
Liquidity Ratios
Current Ratio1.772.129.639.2115.93
Quick Ratio1.641.999.107.8115.37
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-1.12%-1.38%-1.94%-0.37%-0.14%
FCF Yield-0.94%-1.05%-1.05%-0.33%-0.15%
Buyback Yield-1.26%-0.39%-0.35%-0.51%-1.03%